Evofem Q2 FY26 net loss widens to $8.55 million; net product sales fall 45% to $2.63 million - EVFM News | RalliesEvofem Q2 FY26 net loss widens to $8.55 million; net product sales fall 45% to $2.63 million
E
EVFM• Q2 financial results
- Evofem posted Q2 net product sales of $2.63 million, down 45% year over year.
- Cost of goods sold fell 32% to $511,000, partly offset by a $100,000 write-off of excess SOLOSEC inventory.
- Total other expense widened to $8.55 million from $526,000, driven by a $5.7 million fair-value loss on financial instruments.
First-half performance and liquidity
- First-half net product sales dropped 38% to $3.53 million.
- Total other expense swung to a $9.44 million loss from $103,000 income.
- As of June 30, restricted cash and cash equivalents were $300,000, with management citing insufficient liquidity for the next 12 months.
